Literature DB >> 28629934

Recent advances in Leishmania reverse genetics: Manipulating a manipulative parasite.

Samuel M Duncan1, Nathaniel G Jones2, Jeremy C Mottram3.   

Abstract

In this review we describe the expanding repertoire of molecular tools with which to study gene function in Leishmania. Specifically we review the tools available for studying functions of essential genes, such as plasmid shuffle and DiCre, as well as the rapidly expanding portfolio of available CRISPR/Cas9 approaches for large scale gene knockout and endogenous tagging. We include detail on approaches that allow the direct manipulation of RNA using RNAi and protein levels via Tet or DiCre induced overexpression and destabilization domain mediated degradation. The utilisation of current methods and the development of more advanced molecular tools will lead to greater understanding of the role of essential genes in the parasite and thereby more robust drug target validation, thereby paving the way for the development of novel therapeutics to treat this important disease.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug targets; Essential genes; Genome engineering; Leishmania; Leishmaniasis

Mesh:

Year:  2017        PMID: 28629934     DOI: 10.1016/j.molbiopara.2017.06.005

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  13 in total

1.  Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis.

Authors:  Beatriz Coutinho De Oliveira; Malcolm S Duthie; Valéria Rêgo Alves Pereira
Journal:  Hum Vaccin Immunother       Date:  2019-11-11       Impact factor: 3.452

2.  Spontaneous excision and facilitated recovery as a control for phenotypes arising from RNA interference and other dominant transgenes.

Authors:  Erin A Brettmann; Lon-Fye Lye; Stephen M Beverley
Journal:  Mol Biochem Parasitol       Date:  2018-02-03       Impact factor: 1.759

Review 3.  State-of-the-art CRISPR/Cas9 Technology for Genome Editing in Trypanosomatids.

Authors:  Noelia Lander; Miguel A Chiurillo
Journal:  J Eukaryot Microbiol       Date:  2019-07-07       Impact factor: 3.346

4.  Potential of the natural products against leishmaniasis in Old World - a review of in-vitro studies.

Authors:  Sofia Cortes; Carolina Bruno de Sousa; Thiago Morais; João Lago; Lenea Campino
Journal:  Pathog Glob Health       Date:  2020-04-27       Impact factor: 2.894

5.  Inducible high-efficiency CRISPR-Cas9-targeted gene editing and precision base editing in African trypanosomes.

Authors:  Eva Rico; Laura Jeacock; Julie Kovářová; David Horn
Journal:  Sci Rep       Date:  2018-05-21       Impact factor: 4.379

Review 6.  Human Kinetoplastid Protozoan Infections: Where Are We Going Next?

Authors:  Alessandra Almeida Filardy; Kamila Guimarães-Pinto; Marise Pinheiro Nunes; Ketiuce Zukeram; Lara Fliess; Ludimila Pereira; Danielle Oliveira Nascimento; Luciana Conde; Alexandre Morrot
Journal:  Front Immunol       Date:  2018-07-25       Impact factor: 7.561

7.  Catalase impairs Leishmania mexicana development and virulence.

Authors:  Jovana Sádlová; Lucie Podešvová; Tomáš Bečvář; Claretta Bianchi; Evgeny S Gerasimov; Andreu Saura; Kristýna Glanzová; Tereza Leštinová; Nadezhda S Matveeva; Ľubomíra Chmelová; Denisa Mlacovská; Tatiana Spitzová; Barbora Vojtková; Petr Volf; Vyacheslav Yurchenko; Natalya Kraeva
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 8.  Genetically Validated Drug Targets in Leishmania: Current Knowledge and Future Prospects.

Authors:  Nathaniel G Jones; Carolina M C Catta-Preta; Ana Paula C A Lima; Jeremy C Mottram
Journal:  ACS Infect Dis       Date:  2018-02-09       Impact factor: 5.084

9.  High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms.

Authors:  Christopher Fernandez-Prada; Mansi Sharma; Marie Plourde; Eva Bresson; Gaétan Roy; Philippe Leprohon; Marc Ouellette
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-03-16       Impact factor: 4.077

10.  Application of CRISPR/Cas9-Based Reverse Genetics in Leishmania braziliensis: Conserved Roles for HSP100 and HSP23.

Authors:  Vanessa Adaui; Constanze Kröber-Boncardo; Christine Brinker; Henner Zirpel; Julie Sellau; Jorge Arévalo; Jean-Claude Dujardin; Joachim Clos
Journal:  Genes (Basel)       Date:  2020-09-30       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.